Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer ’s disease and associated with CSF-TAU and FDG-PET

ConclusionsKLK6 deserves further investigations as a potential biomarker of Tau pathology in AD.
Source: Translational Neurodegeneration - Category: Neurology Source Type: research